Study protocol: safety and efficacy of propranolol 0.2% eye drops in newborns with a precocious stage of retinopathy of prematurity (DROP-ROP-0.2%): a multicenter, open-label, single arm, phase II trial.

BMC Pediatr · 2017 · PMC5513165 · PMID 28709412

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Recently, also prophylactic propranolol administered on seventh day of life showed a decreasing trend in the incidence of ROP, need for laser therapy, and treatment with anti-VEGF [ 61 ].

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.